Neuroinflammation in Alzheimer's disease and mild cognitive impairment: a field in its infancy.
暂无分享,去创建一个
[1] F. Helmchen,et al. Resting Microglial Cells Are Highly Dynamic Surveillants of Brain Parenchyma in Vivo , 2005, Science.
[2] F. Jessen,et al. Macrophage migration inhibitory factor in mild cognitive impairment and Alzheimer's disease. , 2009, Journal of psychiatric research.
[3] Guy C. Brown,et al. Inflammatory Neurodegeneration Mediated by Nitric Oxide from Activated Glia-Inhibiting Neuronal Respiration, Causing Glutamate Release and Excitotoxicity , 2001, The Journal of Neuroscience.
[4] Binbin Wang,et al. Genetic analysis of tumor necrosis factor-α (TNF-α) G-308A and Saitohin Q7R polymorphisms with Alzheimer's disease , 2008, Journal of the Neurological Sciences.
[5] N. Rothwell,et al. Interleukin‐1‐induced neurotoxicity is mediated by glia and requires caspase activation and free radical release , 2006, Journal of neurochemistry.
[6] C. Wiley,et al. The Positron Emission Tomography Ligand DAA1106 Binds With High Affinity to Activated Microglia in Human Neurological Disorders , 2008, Journal of neuropathology and experimental neurology.
[7] P. Mcgeer,et al. Is there a future for vaccination as a treatment for Alzheimer’s disease? , 2003, Neurobiology of Aging.
[8] G. Halliday,et al. Monocyte Chemoattractant Protein‐1 Plays a Dominant Role in the Chronic Inflammation Observed in Alzheimer's Disease , 2009, Brain pathology.
[9] T. Nabeshima,et al. Protective effects of nicergoline against neuronal cell death induced by activated microglia and astrocytes , 2005, Brain Research.
[10] M. Bukrinsky,et al. Cytokine‐stimulated astrocytes damage human neurons via a nitric oxide mechanism , 1996, Glia.
[11] P. Mcgeer,et al. Astrocytes produce the antiinflammatory and neuroprotective agent hydrogen sulfide , 2009, Neurobiology of Aging.
[12] J. Bełtowski,et al. Hydrogen sulfide (H2S) - the third gas of interest for pharmacologists. , 2007, Pharmacological reports : PR.
[13] B. Gulyás,et al. A comparative autoradiography study in post mortem whole hemisphere human brain slices taken from Alzheimer patients and age-matched controls using two radiolabelled DAA1106 analogues with high affinity to the peripheral benzodiazepine receptor (PBR) system , 2009, Neurochemistry International.
[14] Jialin C. Zheng,et al. Role of activated astrocytes in neuronal damage: Potential links to HIV-1-associated dementia , 2009, Neurotoxicity Research.
[15] C. Szabó. Hydrogen sulphide and its therapeutic potential , 2007, Nature Reviews Drug Discovery.
[16] Xiao-dan Jiang,et al. Genetic Analysis of Interleukin-1A C(-889)T Polymorphism with Alzheimer Disease , 2009, Cellular and Molecular Neurobiology.
[17] C. Plata-salamán,et al. Inflammation and Alzheimer’s disease , 2000, Neurobiology of Aging.
[18] D. Morgan,et al. Microglial Activation is Required for Aβ Clearance After Intracranial Injection of Lipopolysaccharide in APP Transgenic Mice , 2007, Journal of Neuroimmune Pharmacology.
[19] P. Mcgeer,et al. Interferon-γ-dependent cytotoxic activation of human astrocytes and astrocytoma cells , 2009, Neurobiology of Aging.
[20] P. Mcgeer,et al. Proton pump inhibitors exert anti-inflammatory effects and decrease human microglial and monocytic THP-1 cell neurotoxicity , 2009, Experimental Neurology.
[21] S. Skaper. The Brain as a Target for Inflammatory Processes and Neuroprotective Strategies , 2007, Annals of the New York Academy of Sciences.
[22] A. Sparatore,et al. Anti-inflammatory and gastrointestinal effects of a novel diclofenac derivative. , 2007, Free radical biology & medicine.
[23] S. W. Lee,et al. Hydrogen sulfide: Neurochemistry and neurobiology , 2008, Neurochemistry International.
[24] D. Bok. Evidence for an inflammatory process in age-related macular degeneration gains new support. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[25] W. Scheper,et al. The significance of neuroinflammation in understanding Alzheimer’s disease , 2006, Journal of Neural Transmission.
[26] J. Sibley,et al. Sparing of age-related macular degeneration in rheumatoid arthritis , 2005, Neurobiology of Aging.
[27] R. Martins,et al. Type 2 Diabetes: Local Inflammation and Direct Effect of Bacterial Toxic Components , 2008 .
[28] C. Caltagirone,et al. Interleukin 18 gene polymorphisms predict risk and outcome of Alzheimer’s disease , 2007, Journal of Neurology, Neurosurgery & Psychiatry.
[29] R. T. Smith,et al. A common haplotype in the complement regulatory gene factor H (HF1/CFH) predisposes individuals to age-related macular degeneration. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[30] J. Ott,et al. Complement Factor H Polymorphism in Age-Related Macular Degeneration , 2005, Science.
[31] M. Reger,et al. Preserved Cognition in Patients With Early Alzheimer Disease and Amnestic Mild Cognitive Impairment During Treatment With Rosiglitazone: A Preliminary Study , 2005 .
[32] R. Motter,et al. Immunization with amyloid-β attenuates Alzheimer-disease-like pathology in the PDAPP mouse , 1999, Nature.
[33] M. Mullan,et al. CD45 Opposes β-Amyloid Peptide-Induced Microglial Activation via Inhibition of p44/42 Mitogen-Activated Protein Kinase , 2000, The Journal of Neuroscience.
[34] A. Sparatore,et al. Hydrogen sulfide‐releasing NSAIDs attenuate neuroinflammation induced by microglial and astrocytic activation , 2010, Glia.
[35] E. Benveniste,et al. Cytokine actions in the central nervous system. , 1998, Cytokine & growth factor reviews.
[36] P. Mcgeer,et al. Prolyl endopeptidase is revealed following SILAC analysis to be a novel mediator of human microglial and THP‐1 cell neurotoxicity , 2008, Glia.
[37] S. K. Malhotra,et al. Reactive astrocytes: cellular and molecular cues to biological function , 1997, Trends in Neurosciences.
[38] Sunhee C. Lee,et al. Neuronal death in cytokine‐activated primary human brain cell culture: role of tumor necrosis factor‐α , 1999, Glia.
[39] C. Colton,et al. The effects of NOS2 gene deletion on mice expressing mutated human AbetaPP. , 2008, Journal of Alzheimer's disease : JAD.
[40] L. Lue,et al. Expression of inflammatory genes induced by beta-amyloid peptides in human brain endothelial cells and in Alzheimer's brain is mediated by the JNK-AP1 signaling pathway , 2009, Neurobiology of Disease.
[41] R. Veerhuis,et al. Neuroinflammation and regeneration in the early stages of Alzheimer's disease pathology , 2006, International Journal of Developmental Neuroscience.
[42] M. Hallett,et al. Imaging Neuroinflammation in Alzheimer's Disease with Radiolabeled Arachidonic Acid and PET , 2008, Journal of Nuclear Medicine.
[43] K. Abe,et al. The possible role of hydrogen sulfide as an endogenous neuromodulator , 1996, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[44] J. Gilbert,et al. Complement Factor H Variant Increases the Risk of Age-Related Macular Degeneration , 2005, Science.
[45] D. Dickson,et al. Alpha1-antichymotrypsin, an inflammatory protein overexpressed in Alzheimer's disease brain, induces tau phosphorylation in neurons. , 2006, Brain : a journal of neurology.
[46] P. Mcgeer,et al. Inflammatory aspects of Alzheimer disease and other neurodegenerative disorders. , 2008, Journal of Alzheimer's disease : JAD.
[47] M. Schwartz,et al. Activation of microglia by aggregated β-amyloid or lipopolysaccharide impairs MHC-II expression and renders them cytotoxic whereas IFN-γ and IL-4 render them protective , 2005, Molecular and Cellular Neuroscience.
[48] R. Furth. Current view on the mononuclear phagocyte system , 1982 .
[49] C. Lemere,et al. Complement C3 Deficiency Leads to Accelerated Amyloid β Plaque Deposition and Neurodegeneration and Modulation of the Microglia/Macrophage Phenotype in Amyloid Precursor Protein Transgenic Mice , 2008, The Journal of Neuroscience.
[50] S. Heales,et al. Astrocyte‐Derived Nitric Oxide Causes Both Reversible and Irreversible Damage to the Neuronal Mitochondrial Respiratory Chain , 2000, Journal of neurochemistry.